Israeli Naval Medical Institute
Haifa, 2705335, Israel
NCT Number: NCT05657340
This a case control study on seasickness susceptibility. 86 healthy maritime personal were divided to seasickness susceptible and non susceptible groups based on a seasickness questionnaire (Golding) and motion sickness score.
All subjects from both groups underwent video head impulse testing (vHIT). VHIT parameters - gain, asymmetry ect were compared between both groups.
Looking for future studies?
Notify Me18 year–40 year
All sexes
Interventional
Not applicable
Haifa, 2705335, Israel
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Video-head impulse testing is a recent diagnostic bed-side test for evaluation of semi-circular canal function.
Time frame: Immediate
measurement of semicircular canal function
Time frame: Immediate
(|1st canal gain-2nd canal gain|)/(1st canal gain+2nd canal gain)
Time frame: Immediate
anterior semicircular canal gain o ipsilateral horizontal canal gain
Medical Corps, Israel Defense Force
Other
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT02911402
Motion Sickness, Pathological Conditions, Signs and Symptoms
Caen, France
View Trial DetailsNCT06587386
Motion Sickness, Pathological Conditions, Signs and Symptoms
Jiaxing, China
View Trial DetailsNCT04999449
Motion Sickness, Pathological Conditions, Signs and Symptoms
Lebanon, New Hampshire, United States
View Trial DetailsNCT06354309
Amblyopia, Brain Diseases
Shenyang, Liaoning, China
View Trial Details